Table IV.
Factors associated with the decline of qHBsAg values in uni- and multivariate analyses in group 0.
| Factor | Univariate coefficient | P-value | Multivariate coefficient | P-value |
|---|---|---|---|---|
| Gender | −2.064 | 0.039 | −0.099 | 0.257 |
| Age (years) | 0.016 | 0.889 | ||
| Family HBV infection history | −2.180a | 0.029 | −0.105 | 0.227 |
| Initial AST | −0.166 | 0.082 | ||
| Initial ALT | −0.092 | 0.337 | ||
| Initial Total bilirubin | −0.053 | 0.579 | ||
| Initial LS | −0.074 | 0.441 | ||
| Initial qHBsAg | 0.462 | <0.001 | 0.460 | <0.001 |
| Initial AFP | −0.045 | 0.639 | ||
| HBeAg | 0.044 | 0.645 | ||
| Initial HBV DNA | 0.158 | 0.099 | ||
| Initial PTA | 0.049 | 0.611 | ||
| Therapy before initial LSM | 0.017 | 0.857 | ||
| Changes of HBV DNA | 0.011 | 0.910 | ||
| Initial platelets | 0.008 | 0.932 | ||
| Initial Cr | 0.062 | 0.519 | ||
| Initial BUN | 0.097 | 0.310 | ||
| Initial ALB | 0.100 | 0.294 | ||
| Initial triglycerides | 0.005 | 0.962 |
a
Mann-Whitney U test. qHBsAg, quantitative hepatitis B surface antigen; AST, aspartate aminotransferase; ALT, alanine aminotransferase; TBIL, total bilirubin; AFP, α-fetoprotein; PTA, prothrombin time activity; Cr, creatinine; BUN, blood urea nitrogen; ALB, albumin; HBV, hepatitis B virus; LSM, liver stiffness measurement.